Meeting
2021 Genitourinary Cancers Symposium
Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.
Authors
Raquibul Hannan
University of Texas Southwestern Medical Center, Dallas, TX
Raquibul Hannan , Michael Christensen , Liliana Robles , Alana Christie , Aurelie Garant , Neil Bipinchandra Desai , Hans J. Hammers , Waddah Arafat , Isaac Alexander Bowman , Suzanne Cole , Kevin Dale Courtney , Solomon L. Woldu , Aditya Bagrodia , Vitaly Margulis , Jeffrey A Cadeddu , Hak Choy , David Sher , James Brugarolas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT02956798
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 311)
DOI
10.1200/JCO.2021.39.6_suppl.311
Abstract #
311
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Phase II trial of stereotactic ablative radiation (SAbR) for oligoprogressive kidney cancer.
First Author: Raquibul Hannan
Poster
2019 Genitourinary Cancers Symposium
Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer.
First Author: Yuanyuan Zhang
Poster
2017 ASCO Annual Meeting
A phase II randomized trial of observation versus stereotactic ablative radiation for oligometastatic prostate cancer (ORIOLE).
First Author: Ryan Phillips
Poster
2024 ASCO Genitourinary Cancers Symposium
Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).
First Author: Raquibul Hannan